🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This trial is an open, phase II clinical study. The study is divided into t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-09-30
Trial ID
NCT05775874
Treatments Being Tested
Phase 1b clinical study to evaluate the PK of oral AZD4547 in Chinese patie...
Status
Unknown
Location
Fudan University Cancer Hospital
Start Date
2021-06-03
Trial ID
NCT05086666
Treatments Being Tested
The primary purpose of this study is to explore the safety and tolerability...
Status
Completed
Location
Research Site
Start Date
2010-11
Trial ID
NCT01213160
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935
The purpose of this study is to assess the safety and effectiveness of AZD4...
Status
Completed
Location
Research Site
Start Date
2010-12
Trial ID
NCT01202591
Treatments Being Tested
This phase II/III trial studies how well FGFR inhibitor AZD4547 (AZD4547) w...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-10
Trial ID
NCT02965378
Treatments Being Tested
This phase II MATCH screening and multi-sub-trial studies how well treatmen...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2015-08-17
Trial ID
NCT02465060
Treatments Being Tested
In this study, a single oral dose of the tablet formulation administered un...
Status
Completed
Location
Tri-Service General Hospital
Start Date
2020-09-08
Trial ID
NCT05533788
Treatments Being Tested
This randomized phase I/II trial studies the side effects and best dose of ...
Status
Completed
Location
Emory University
Start Date
2014-01-15
Trial ID
NCT01824901